One important aspect of patient support is helping people navigate insurance issues. In fact, outside of treatment options, insurance issues are the second biggest patient education topic for The Elliott Foundation and an important part of our Integrated Patient Support Program. That is why we are glad to pass along that The Musella Foundation is now […]
Brad loved the stars as a dedicated astronomer and according to family and friends, he could build and fix anything. It was a gift, and Brad used his gift to help anyone and everyone and even to earn awards as an amateur builder of power reflector telescopes. In August 2010 Brad lost a two-year battle with […]
“After graduating with a Marketing degree from San Diego State in 1987, I somehow ended up in the hotel industry as a catering manager, planning meetings and weddings. Feeling unsettled in my job by the time 1997 came around I was looking for a new direction. After much aptitude testing, a career counselor suggested I […]
We are so excited to share this with you. The Chris Elliott Fund has now become The Elliott Foundation! We are starting 2012 with an expanded vision, a new name, and a new look. All of the rebranding and what we call our “capacity build out” project is designed to […]
Hi Dellann, I’ve been listening to your radio talk show from January 4th. I wanted to let you know that their write up has the wrong date listed for your tour of the Ivy Brain Center and Cyber Knife you mentioned. It says January 19th vs January 16th. We actually have an appt with Dr. […]
• Over 60,000 brain cancer patients, family members, and caregivers received vital information and support about advanced brain tumor treatment and access to advanced treatment centers known for their excellence. • In April, the FDA approved NovoTTF device as a new treatment option for brain cancer. CEF President Dellann Elliott testified before the FDA as […]
Dear Ms. Elliott: Thank you for contacting me with your support for funding of the National Institutes of Health (NIH). It is good to hear from you. As a member of the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, I have been very supportive of funding for biomedical research […]
The study is a prospective, randomly controlled pivotal trial, designed to test the efficacy and safety of a medical device, the NovoTTF-100A, as an adjuvant to the best standard of care in the treatment of newly diagnosed GBM patients. The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields […]
“When my son was first diagnosed with a GBM, we were scared but determined to fight. We started searching for answers on the internet right away, and as you can imagine, we found a lot of bad information along with a lot of good information. It was hard to tell what was good advice and […]
You have been following all of it here on FaceBook. The testimoney and the FDA hearings back in March and then, just a few days ago last month, the Chris Elliott Fund (CEF) and I were honored at the National Brain Tumor Society’s Annual Mtg. & Summit/Conference in Philadelphia, specifically for the quality and thoroughness of the […]
